low participant accrual
Sponsor study identifier
interventional
14
1 country
1
Study Start
December 9, 2009
Actual (reported)Primary Completion
April 22, 2016
Actual (reported)Study Completion
September 8, 2016
Actual (reported)The purpose of this study is to determine if Conformal High Dose Intensity Modulated Radiation Therapy is an appropriate option for treating cancer that has spread to the spinal column. This study involves patients who have been diagnosed with metastatic cancer to the thoracic and lumbar vertebral body levels and currently do not have symptoms caused from the area of concern. The goal is to prove that this is not only a safe form of treatment, but that Conformal High Dose Intensity Modulated Radiation Therapy can reduce the risk of cancer coming back in the area that the investigators treat which may reduce the risk of developing symptoms like pain in the future.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 8, 2016
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 9, 2009
Actual (reported)July 17, 2012
Actual (reported)July 31, 2012
Actual (reported)April 22, 2016
Actual (reported)September 8, 2016
Actual (reported)April 19, 2019
Actual (reported)Time to Any Skeletal Related Event
Time to any skeletal related event most commonly symptomatic recurrence or progression with pain/neurologic impairment with evidence of radiographic progression (median local progression-free survival).
up to 24 months
Acute Radiation Toxicity
90 days
Late Radiation Toxicity
2 years
Conformal High Dose Intensity Modulated Radiation Therapy to a single asymptomatic local spine metastasis.
Conformal High Dose Intensity Modulated Radiation Therapy 14-16Gy single fraction dosing using 6MV photons
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University of Kentucky
Lexington, Kentucky, 40536, United States
Ronald McGarry, M.D.
University of Kentucky
14 participants (actual enrollment reported by the registry).
First Submitted
July 17, 2012
First Posted
July 31, 2012
Study Start
December 9, 2009
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
April 22, 2016
Actual (reported)Study Completion
September 8, 2016
Actual (reported)Last Updated
April 19, 2019
Results First Posted
April 19, 2019
Record last verified: 2019-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: